Abstract
Biotechnology Law ReportVol. 21, No. 2 PapersLegal Status and Patentability of Stem Cells in EuropeDr. Tade Matthias SprangerDr. Tade Matthias SprangerSearch for more papers by this authorPublished Online:5 Jul 2004https://doi.org/10.1089/07300310252962019AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited byLegal Implications of Therapeutic Options — Stem Cell Procedures, Cloning and PatentsPatent or perish? An ethical approach to patenting human genes and proteins21 January 2003 | The Pharmacogenomics Journal, Vol. 2, No. 6 Volume 21Issue 2Apr 2002 To cite this article:Dr. Tade Matthias Spranger.Legal Status and Patentability of Stem Cells in Europe.Biotechnology Law Report.Apr 2002.105-112.http://doi.org/10.1089/07300310252962019Published in Volume: 21 Issue 2: July 5, 2004PDF download
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
